Easywell Biomedicals Statistics
Total Valuation
TPEX:1799 has a market cap or net worth of TWD 4.15 billion. The enterprise value is 4.14 billion.
| Market Cap | 4.15B |
| Enterprise Value | 4.14B |
Important Dates
The next estimated earnings date is Tuesday, August 11, 2026.
| Earnings Date | Aug 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:1799 has 124.69 million shares outstanding. The number of shares has increased by 2.74% in one year.
| Current Share Class | 124.69M |
| Shares Outstanding | 124.69M |
| Shares Change (YoY) | +2.74% |
| Shares Change (QoQ) | -0.33% |
| Owned by Insiders (%) | 7.93% |
| Owned by Institutions (%) | n/a |
| Float | 64.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.07 |
| PB Ratio | 5.65 |
| P/TBV Ratio | 6.58 |
| P/FCF Ratio | 27.97 |
| P/OCF Ratio | 25.83 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 90.24, with an EV/FCF ratio of 27.91.
| EV / Earnings | -79.35 |
| EV / Sales | 6.06 |
| EV / EBITDA | 90.24 |
| EV / EBIT | n/a |
| EV / FCF | 27.91 |
Financial Position
The company has a current ratio of 2.45, with a Debt / Equity ratio of 0.59.
| Current Ratio | 2.45 |
| Quick Ratio | 1.84 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | 9.39 |
| Debt / FCF | 2.90 |
| Interest Coverage | -2.12 |
Financial Efficiency
Return on equity (ROE) is -7.09% and return on invested capital (ROIC) is -2.20%.
| Return on Equity (ROE) | -7.09% |
| Return on Assets (ROA) | -1.96% |
| Return on Invested Capital (ROIC) | -2.20% |
| Return on Capital Employed (ROCE) | -4.18% |
| Weighted Average Cost of Capital (WACC) | 3.95% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.91 |
Taxes
In the past 12 months, TPEX:1799 has paid 151,000 in taxes.
| Income Tax | 151,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -40.39% in the last 52 weeks. The beta is -0.05, so TPEX:1799's price volatility has been lower than the market average.
| Beta (5Y) | -0.05 |
| 52-Week Price Change | -40.39% |
| 50-Day Moving Average | 38.09 |
| 200-Day Moving Average | 38.51 |
| Relative Strength Index (RSI) | 34.48 |
| Average Volume (20 Days) | 154,465 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:1799 had revenue of TWD 682.56 million and -52.13 million in losses. Loss per share was -0.42.
| Revenue | 682.56M |
| Gross Profit | 320.18M |
| Operating Income | -43.65M |
| Pretax Income | -52.25M |
| Net Income | -52.13M |
| EBITDA | 26.47M |
| EBIT | -43.65M |
| Loss Per Share | -0.42 |
Balance Sheet
The company has 453.57 million in cash and 430.24 million in debt, with a net cash position of 23.33 million or 0.19 per share.
| Cash & Cash Equivalents | 453.57M |
| Total Debt | 430.24M |
| Net Cash | 23.33M |
| Net Cash Per Share | 0.19 |
| Equity (Book Value) | 733.16M |
| Book Value Per Share | 5.77 |
| Working Capital | 425.01M |
Cash Flow
In the last 12 months, operating cash flow was 160.52 million and capital expenditures -12.31 million, giving a free cash flow of 148.21 million.
| Operating Cash Flow | 160.52M |
| Capital Expenditures | -12.31M |
| Depreciation & Amortization | 70.11M |
| Net Borrowing | -128.50M |
| Free Cash Flow | 148.21M |
| FCF Per Share | 1.19 |
Margins
Gross margin is 46.91%, with operating and profit margins of -6.39% and -7.64%.
| Gross Margin | 46.91% |
| Operating Margin | -6.39% |
| Pretax Margin | -7.65% |
| Profit Margin | -7.64% |
| EBITDA Margin | 3.88% |
| EBIT Margin | -6.39% |
| FCF Margin | 21.71% |
Dividends & Yields
TPEX:1799 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.74% |
| Shareholder Yield | -2.74% |
| Earnings Yield | -1.26% |
| FCF Yield | 3.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 30, 2022. It was a reverse split with a ratio of 0.7.
| Last Split Date | Sep 30, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.7 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |